Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
METHOD OF TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR; ANTIBODY THAT BINDS TO PROGRAMMED DEATH-1 RECEPTOR (PD-1) OR PROGRAMMED DEATH LIGAND 1 (PD-L1)

No-Receipt date 2021-00640 - 18/02/2021
No-Filing date 20210400451 - 18/02/2021
No-Granting date 3106454 - 03/03/2021
No-EPO application date 16744626.9 - 14/07/2016
No-EPO granting date 3322731 - 13/01/2021
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 3/2021 - 16/04/2021
Expiration date 15/07/2036
Kind of title Validation of European Patent
Legal status VALID
Priorities US201562192396 P14/07/2015/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61K 39/00
A61K 39/395
A61P 35/00
C07K 16/28
C12Q 1/6886
C12Q 1/70
G01N 33/574

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1283664 BRISTOL-MYERS SQUIBB COMPANY ROUTE 206 AND PROVINCE LINE ROADPRINCETON, NJ 08543 UNITED STATES OF AMERICA (USA)

Inventors
CodeFirstnameSurname
3282482 MANEKAS, DEMETRIOS
3282483 GROSSO, JOSEPH
3282484 ANDERSON, JEFFREY

Representatives
CodeFirstnameSurnameAddressTownZip
3712ANTHOULAGALANOPOULOUTHESI LYSI MPITAKOUKAPANDRITI (ATTIKIS)19014

Contact
CodeFirstnameSurnameAddressTownZipCountry
9219ALKISTIS-EIRINIMALAMIVISSARIONOS 3ATHINA (ATTIKIS)10672 GREECE

Owners History

Title Instruments

Payments history 9 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015